Jo Y - Search Results

1

Locally recurrent prostate cancer after high-dose-rate brachytherapy: the value of diffusion-weighted imaging, dynamic contrast-enhanced MRI, and T2-weighted imaging in localizing tumors.

Tamada T, Sone T, Jo Y, Hiratsuka J, Higaki A, Higashi H, Ito K. Tamada T, et al. Among authors: jo y. AJR Am J Roentgenol. 2011 Aug;197(2):408-14. doi: 10.2214/AJR.10.5772. AJR Am J Roentgenol. 2011. PMID: 21785087

2

Clinical results of combined treatment conformal high-dose-rate iridium-192 brachytherapy and external beam radiotherapy using staging lymphadenectomy for localized prostate cancer.

Hiratsuka J, Jo Y, Yoshida K, Nagase N, Fujisawa M, Imajo Y. Hiratsuka J, et al. Among authors: jo y. Int J Radiat Oncol Biol Phys. 2004 Jul 1;59(3):684-90. doi: 10.1016/j.ijrobp.2003.11.035. Int J Radiat Oncol Biol Phys. 2004. PMID: 15183471

3

Prostate cancer detection in patients with total serum prostate-specific antigen levels of 4-10 ng/mL: diagnostic efficacy of diffusion-weighted imaging, dynamic contrast-enhanced MRI, and T2-weighted imaging.

Tamada T, Sone T, Higashi H, Jo Y, Yamamoto A, Kanki A, Ito K. Tamada T, et al. Among authors: jo y. AJR Am J Roentgenol. 2011 Sep;197(3):664-70. doi: 10.2214/AJR.10.5923. AJR Am J Roentgenol. 2011. PMID: 21862809

4

Salvage high-dose-rate brachytherapy for local prostate cancer recurrence after radiotherapy - preliminary results.

Jo Y, Fujii T, Hara R, Yokoyama T, Miyaji Y, Yoden E, Hiratsuka J, Nagai A. Jo Y, et al. BJU Int. 2012 Mar;109(6):835-9. doi: 10.1111/j.1464-410X.2011.10519.x. Epub 2011 Sep 20. BJU Int. 2012. PMID: 21933327

5

[High-dose-rate brachytherapy for prostate cancer].

Jo Y, Nagai A, Hiratsuka J. Jo Y, et al. Nihon Rinsho. 2011 Jun;69 Suppl 5:447-50. Nihon Rinsho. 2011. PMID: 22208020 Japanese. No abstract available.

6

Diffusion-weighted MRI and its role in prostate cancer.

Tamada T, Sone T, Jo Y, Yamamoto A, Ito K. Tamada T, et al. Among authors: jo y. NMR Biomed. 2014 Jan;27(1):25-38. doi: 10.1002/nbm.2956. Epub 2013 May 27. NMR Biomed. 2014. PMID: 23712781 Review.

7

High b value (2,000 s/mm2) diffusion-weighted magnetic resonance imaging in prostate cancer at 3 Tesla: comparison with 1,000 s/mm2 for tumor conspicuity and discrimination of aggressiveness.

Tamada T, Kanomata N, Sone T, Jo Y, Miyaji Y, Higashi H, Yamamoto A, Ito K. Tamada T, et al. Among authors: jo y. PLoS One. 2014 May 6;9(5):e96619. doi: 10.1371/journal.pone.0096619. eCollection 2014. PLoS One. 2014. PMID: 24802652 Free PMC article.

8

Value of preoperative 3T multiparametric MRI for surgical margin status in patients with prostate cancer.

Tamada T, Sone T, Kanomata N, Miyaji Y, Kido A, Jo Y, Yamamoto A, Ito K. Tamada T, et al. Among authors: jo y. J Magn Reson Imaging. 2016 Sep;44(3):584-93. doi: 10.1002/jmri.25185. Epub 2016 Feb 13. J Magn Reson Imaging. 2016. PMID: 26872679

9

T2-weighted MR imaging of prostate cancer: multishot echo-planar imaging vs fast spin-echo imaging.

Tamada T, Sone T, Nagai K, Jo Y, Gyoten M, Imai S, Kajihara Y, Fukunaga M. Tamada T, et al. Among authors: jo y. Eur Radiol. 2004 Feb;14(2):318-25. doi: 10.1007/s00330-003-2118-y. Epub 2003 Oct 18. Eur Radiol. 2004. PMID: 14566427

10

Prostate cancer: relationships between postbiopsy hemorrhage and tumor detectability at MR diagnosis.

Tamada T, Sone T, Jo Y, Yamamoto A, Yamashita T, Egashira N, Imai S, Fukunaga M. Tamada T, et al. Among authors: jo y. Radiology. 2008 Aug;248(2):531-9. doi: 10.1148/radiol.2482070157. Epub 2008 Jun 6. Radiology. 2008. PMID: 18539890

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,957 results

Search Page

Filters